We attend to “Advanced Therapies” from research to market authorization.

Since regenerative medicine is a very recent field there are still no standard ways to translate an idea to the corresponding end product for all participants including scientists, clinicians, authority- and health insurance-employees. A standardised translation procedure as it is well known from the medicinal product development does not (yet) exist for the ATMPs.

The ATP-consultants have many year experience in this field. Their knowledge ranges from research and clinical practice to regulatory requirements for pre-clinic and clinic studies as well as authorisation and reimbursement procedures. The consultants have many years of experience to link all of these platforms to a successful project.

The ATP consulting activities bring the efficient regenerative therapies fast and effectively to the persons who need them: the patients. Importantly, their experience also guarantees rigorous security and quality standards. In order to cover all fields of Regenerative Medicine and in order to meet the consulting needs, the ATP cooperates with a competent expert-network.